(VIANEWS) – Open Text Corporation (OTEX), Century Casinos (CNTY), Harmony Biosciences Holdings (HRMY) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Open Text Corporation (OTEX)
69.1% sales growth and 7.37% return on equity
Open Text Corporation engages in the designs, develops, markets, and sells information management software and solutions. It offers content services; business network that manages data within the organization and outside the firewall; security and protection solutions for defending against cyber threats, and preparing for business continuity and response in the event of a breach; digital investigation and forensic security solutions; OpenText security solutions to address information cyber resilience needs; Carbonite and Webroot products; and OpenText Information Management software platform. The company also provides Discovery platform that provides forensics and unstructured data analytics; OpenText Developer Cloud; key developer API services; AI and analytics that leverages structured or unstructured data; digital process automation solutions, which enables organizations to transform into digital data-driven businesses; and OpenText Digital Experience platform. In addition, it offers customer support programs, including access to software upgrades, a knowledge base, discussions, product information, and an online mechanism to post and review trouble tickets; and consulting and learning services relating to the implementation, training, and integration of its licensed product offerings, as well as cloud services. The company serves organizations, enterprise and mid-market companies, public sector agencies, small and medium-sized businesses, and direct consumers in Canada, the United States, the United Kingdom, Germany, rest of Europe, the Middle East, Africa, and internationally. It has strategic partnerships with SAP SE, Google Cloud, Amazon AWS, Microsoft Corporation, Oracle Corporation, Salesforce.com Corporation, Accenture plc, ATOS, Capgemini Technology Services SAS, Cognizant Technology Solutions U.S. Corp., Deloitte Consulting LLP, and Tata Consultancy Services. The company was incorporated in 1991 and is headquartered in Waterloo, Canada.
Earnings Per Share
As for profitability, Open Text Corporation has a trailing twelve months EPS of $1.11.
PE Ratio
Open Text Corporation has a trailing twelve months price to earnings ratio of 37.43. Meaning, the purchaser of the share is investing $37.43 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.37%.
2. Century Casinos (CNTY)
46.5% sales growth and 9.13% return on equity
Century Casinos, Inc. operates as a casino entertainment company worldwide. The company develops and operates gaming establishments, as well as related lodging, restaurant, horse racing, and entertainment facilities. As of March 12, 2021, it operated four ship-based casinos. The company was founded in 1992 and is based in Colorado Springs, Colorado.
Earnings Per Share
As for profitability, Century Casinos has a trailing twelve months EPS of $0.2.
PE Ratio
Century Casinos has a trailing twelve months price to earnings ratio of 36.5. Meaning, the purchaser of the share is investing $36.5 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.13%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.2%, now sitting on 435.93M for the twelve trailing months.
Volume
Today’s last reported volume for Century Casinos is 38375 which is 28.21% below its average volume of 53459.
3. Harmony Biosciences Holdings (HRMY)
33.2% sales growth and 57.63% return on equity
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy in the United States. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
Earnings Per Share
As for profitability, Harmony Biosciences Holdings has a trailing twelve months EPS of $3.05.
PE Ratio
Harmony Biosciences Holdings has a trailing twelve months price to earnings ratio of 11.14. Meaning, the purchaser of the share is investing $11.14 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 57.63%.
Volume
Today’s last reported volume for Harmony Biosciences Holdings is 501801 which is 8.46% below its average volume of 548214.
Yearly Top and Bottom Value
Harmony Biosciences Holdings’s stock is valued at $33.99 at 20:22 EST, way under its 52-week high of $62.08 and way above its 52-week low of $29.81.
Moving Average
Harmony Biosciences Holdings’s value is under its 50-day moving average of $35.28 and way below its 200-day moving average of $44.81.
Sales Growth
Harmony Biosciences Holdings’s sales growth is 33.2% for the current quarter and 33.2% for the next.
4. The Ensign Group (ENSG)
24.9% sales growth and 19.61% return on equity
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in two segments, Skilled Services and Real Estate. The company offers skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional programs, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of April 4, 2022, it operated 252 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
Earnings Per Share
As for profitability, The Ensign Group has a trailing twelve months EPS of $4.08.
PE Ratio
The Ensign Group has a trailing twelve months price to earnings ratio of 23.57. Meaning, the purchaser of the share is investing $23.57 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.61%.
5. Telefonica Brasil, S.A. ADS (VIV)
10.1% sales growth and 5.96% return on equity
Telef̫nica Brasil S.A., together with its subsidiaries, provides mobile and fixed telecommunications services to residential and corporate customers in Brazil. Its fixed line services portfolio includes local, domestic long-distance, and international long-distance calls; and mobile portfolio comprises voice and broadband internet access through 3G, 4G, 4.5G, and 5G as well as mobile value-added services and wireless roaming services. The company also offers data services, including broadband and mobile data services. In addition, it provides pay TV services through direct to home satellite technology, IPTV, and cable, as well as pay-per-view and video on demand services; network services, such as rental of facilities; other services comprising internet access, private network connectivity, computer equipment leasing, extended service, caller identification, voice mail, cellular blocker, and others; wholesale services, including interconnection services to users of other network providers; and digital services, such as entertainment, cloud, and security and financial services. Further, the company offers multimedia communication services, which include audio, data, voice and other sounds, images, texts, and other information, as well as sells devices, such as smartphones, broadband USB modems, and other devices. Additionally, it provides telecommunications solutions and IT support to various industries, such as retail, manufacturing, services, financial institutions, government, etc. It markets and sells its solutions through own stores, dealers, retail and distribution channels, door-to-door sales, and outbound tele sales. The company was formerly known as Telecomunica̵̤es de Ṣo Paulo S.A. РTELESP and changed its name to Telef̫nica Brasil S.A. in October 2011. The company was incorporated in 1998 and is headquartered in Ṣo Paulo, Brazil.
Earnings Per Share
As for profitability, Telefonica Brasil, S.A. ADS has a trailing twelve months EPS of $0.51.
PE Ratio
Telefonica Brasil, S.A. ADS has a trailing twelve months price to earnings ratio of 17.43. Meaning, the purchaser of the share is investing $17.43 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.96%.
Volume
Today’s last reported volume for Telefonica Brasil, S.A. ADS is 1649820 which is 8.51% below its average volume of 1803320.
6. Core Laboratories N.V. (CLB)
9% sales growth and 13.06% return on equity
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products; and proprietary and joint industry studies. The Production Enhancement segment offers services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amstelveen, the Netherlands.
Earnings Per Share
As for profitability, Core Laboratories N.V. has a trailing twelve months EPS of $0.51.
PE Ratio
Core Laboratories N.V. has a trailing twelve months price to earnings ratio of 44.94. Meaning, the purchaser of the share is investing $44.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.06%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 75% and 33.3%, respectively.
Yearly Top and Bottom Value
Core Laboratories N.V.’s stock is valued at $22.92 at 20:22 EST, way below its 52-week high of $26.80 and way above its 52-week low of $13.19.
7. Ecolab (ECL)
7.9% sales growth and 16.2% return on equity
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences segments. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, refining, and petrochemical industries. The Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. Its Global Healthcare & Life Sciences segment offers specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries, such as infection prevention and surgical solutions, and end-to-end cleaning and contamination control solutions under the Ecolab, Microtek, and Anios brand names. The company's Other segment offers pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations, and other institutional and commercial customers. This segment also provides colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries; and products and services that manage wash process through custom designed programs, premium products, dispensing equipment, water and energy management, and reduction, as well as real time data management. It sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.
Earnings Per Share
As for profitability, Ecolab has a trailing twelve months EPS of $4.01.
PE Ratio
Ecolab has a trailing twelve months price to earnings ratio of 45.95. Meaning, the purchaser of the share is investing $45.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.2%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jun 15, 2023, the estimated forward annual dividend rate is 2.12 and the estimated forward annual dividend yield is 1.17%.
Yearly Top and Bottom Value
Ecolab’s stock is valued at $184.25 at 20:22 EST, below its 52-week high of $187.73 and way above its 52-week low of $131.04.
Moving Average
Ecolab’s worth is higher than its 50-day moving average of $173.75 and way higher than its 200-day moving average of $157.85.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 10% and 13.1%, respectively.
